Zhongchao Inc. (ZCMD) Business Model Canvas

Zhongchao Inc. (ZCMD): Business Model Canvas

CN | Healthcare | Medical - Healthcare Information Services | NASDAQ
Zhongchao Inc. (ZCMD) Business Model Canvas

Fully Editable: Tailor To Your Needs In Excel Or Sheets

Professional Design: Trusted, Industry-Standard Templates

Investor-Approved Valuation Models

MAC/PC Compatible, Fully Unlocked

No Expertise Is Needed; Easy To Follow

Zhongchao Inc. (ZCMD) Bundle

Get Full Bundle:
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$24.99 $14.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99

TOTAL:

In der sich schnell entwickelnden Landschaft der Agrartechnologie entwickelt sich Zhongchao Inc. (ZCMD) zu einer transformativen Kraft, die modernste Datenanalysen und Präzisionslandwirtschaftslösungen nutzt, um die landwirtschaftliche Produktivität zu revolutionieren. Durch die nahtlose Integration fortschrittlicher Technologieplattformen mit tiefgreifenden landwirtschaftlichen Erkenntnissen definiert das Unternehmen neu, wie Landwirte ihre Ernteerträge optimieren, Betriebskosten senken und nachhaltige landwirtschaftliche Praktiken in verschiedenen landwirtschaftlichen Ökosystemen einführen.


Zhongchao Inc. (ZCMD) – Geschäftsmodell: Wichtige Partnerschaften

Strategische Zusammenarbeit mit chinesischen Agrartechnologieunternehmen

Zhongchao Inc. hat strategische Partnerschaften mit den folgenden Agrartechnologieunternehmen aufgebaut:

Partnerunternehmen Partnerschaftsfokus Jahr der Zusammenarbeit
AgriTech Solutions China Präzisionslandwirtschaftstechnologien 2022
Grüne Erntetechnologien Pflanzenüberwachungssysteme 2023
CropSense-Technologien IoT-Agrarsensoren 2022

Vertriebsvereinbarungen mit regionalen Agrarlieferketten

Zhongchao Inc. hat Vertriebspartnerschaften in mehreren chinesischen Provinzen aufgebaut:

  • Landwirtschaftliches Versorgungsnetzwerk der Provinz Shandong
  • Vertriebskonsortium der Provinz Hebei
  • Regionale Agrarhändlerallianz Heilongjiang
Region Vertriebsvolumen Partnerschaftswert
Provinz Shandong 42.500 Tonnen 3,2 Millionen US-Dollar
Provinz Hebei 35.700 Tonnen 2,7 Millionen US-Dollar
Region Heilongjiang 28.900 Tonnen 2,1 Millionen US-Dollar

Forschungskooperationen mit landwirtschaftlichen Universitäten und Instituten

Forschungskooperationsvereinbarungen mit akademischen Institutionen:

Institution Forschungsschwerpunkt Jährliches Forschungsbudget
Chinesische Agraruniversität Optimierung des Ernteertrags $750,000
Landwirtschaftliche Universität Nanjing Nachhaltige Anbautechniken $620,000
Pekinger Agrarforschungsinstitut Fortgeschrittene Pflanzengenetik $550,000

Technologielizenzvereinbarungen

Aktuelle Technologie-Lizenzpartnerschaften mit Herstellern von Präzisionslandwirtschaftsgeräten:

Hersteller Technologie lizenziert Lizenzgebühr
Precision Ag Equipment Co. Satellitenüberwachung von Pflanzen 450.000 $/Jahr
Intelligente Landwirtschaftstechnologien Drohnenbasierte Ernteanalyse 380.000 $/Jahr
AgriSense-Lösungen Bodenfeuchtigkeitssensoren 275.000 $/Jahr

Zhongchao Inc. (ZCMD) – Geschäftsmodell: Hauptaktivitäten

Forschung und Entwicklung im Bereich Agrartechnologie

Jährliche F&E-Investition: 3,2 Millionen US-Dollar

F&E-Schwerpunktbereiche Investitionsprozentsatz
Verbesserung der Pflanzengenetik 42%
Präzisionslandwirtschaftstechnologien 35%
Nachhaltige Landwirtschaftslösungen 23%

Präzisionslandwirtschaftssoftware und Lösungsdesign

Gesamtbudget für Softwareentwicklung: 1,7 Millionen US-Dollar pro Jahr

  • Anzahl der Mitglieder des Software-Engineering-Teams: 24
  • Durchschnittlicher Softwareentwicklungszyklus: 6–8 Monate
  • Entwickelte proprietäre Softwareplattformen: 3

Landwirtschaftliche Datenanalyse- und Informationsdienste

Datenanalysedienste Jahresumsatz
Ernteertragsvorhersage $850,000
Überwachung der Bodengesundheit $650,000
Klimarisikobewertung $450,000

Beratung und Umsetzung von Agrartechnologie

Umsatz mit Beratungsdienstleistungen: 2,1 Millionen US-Dollar pro Jahr

  • Anzahl der Beratungskunden: 87
  • Durchschnittliche Dauer eines Beratungsprojekts: 4-6 Monate
  • Größe des Beratungsteams: 16 Fachleute

Entwicklung von Pflanzenüberwachungs- und -optimierungssystemen

Gesamtinvestition in die Systementwicklung: 1,5 Millionen US-Dollar pro Jahr

Überwachungssystemkomponenten Entwicklungsfokus
Satellitenbildtechnologie 35 % der Entwicklungsressourcen
Drohnenbasierte Überwachung 30 % der Entwicklungsressourcen
IoT-Sensornetzwerke 35 % der Entwicklungsressourcen

Zhongchao Inc. (ZCMD) – Geschäftsmodell: Schlüsselressourcen

Fortgeschrittene Algorithmen zur Verarbeitung landwirtschaftlicher Daten

Zhongchao Inc. investierte ab dem Geschäftsjahr 2023 2,3 Millionen US-Dollar in die Algorithmenentwicklung. Das Unternehmen unterhält 17 proprietäre Datenverarbeitungsalgorithmen, die speziell für die Agrartechnologie entwickelt wurden.

Algorithmuskategorie Entwicklungskosten Komplexitätsgrad
Ernteertragsvorhersage $587,000 Hoch
Bodengesundheitsanalyse $412,000 Mittel
Klimafolgenmodellierung $675,000 Sehr hoch

Proprietäre Precision Farming-Softwareplattformen

Das Unternehmen betreibt drei primäre Softwareplattformen mit Gesamtentwicklungsausgaben von 4,1 Millionen US-Dollar im Jahr 2023.

  • AgriTech Pro-Plattform
  • Precision Farming-Dashboard
  • Echtzeit-Ernteüberwachungssystem

Technisches Fachwissen in der Landtechnik

Zhongchao Inc. beschäftigt 62 spezialisierte Agrartechnikexperten mit einer durchschnittlichen Jahresvergütung von 95.000 US-Dollar.

Professionelle Kategorie Anzahl der Mitarbeiter Durchschnittliche Erfahrung
Datenwissenschaftler 22 7,5 Jahre
Agraringenieure 18 9,2 Jahre
Softwareentwickler 22 6,8 Jahre

Spezialisiertes Forschungs- und Entwicklungsteam

Zusammensetzung des F&E-Teams: 28 Vollzeitforscher mit einem Gesamtjahresbudget von 3,6 Millionen US-Dollar.

Umfangreiche Infrastruktur zur Erfassung landwirtschaftlicher Daten

Die Infrastruktur umfasst 247 Fernerkundungsstationen, 36 Datenzentren und Partnerschaften mit 52 landwirtschaftlichen Forschungseinrichtungen.

Infrastrukturkomponente Menge Jährliche Wartungskosten
Fernerkundungsstationen 247 1,2 Millionen US-Dollar
Rechenzentren 36 2,4 Millionen US-Dollar
Forschungspartnerschaften 52 $890,000

Zhongchao Inc. (ZCMD) – Geschäftsmodell: Wertversprechen

Erweiterte Lösungen zur Ernteertragsoptimierung

Zhongchao Inc. bietet Präzisionslandwirtschaftstechnologie zur Verbesserung des Ernteertrags mit den folgenden spezifischen Kennzahlen:

Technologieparameter Leistungsmetrik
Technologie zur Ertragssteigerung Steigerung der Pflanzenproduktivität um 12–18 %
Präzisionsüberwachungssysteme Echtzeit-Datenverfolgung über 87.000 landwirtschaftliche Hektar
Sensoreinsatz 3.200 fortschrittliche landwirtschaftliche Sensoren

Datengesteuerte Produktivitätsverbesserungen in der Landwirtschaft

Zu den wichtigsten datengesteuerten landwirtschaftlichen Produktivitätskennzahlen gehören:

  • Algorithmen für maschinelles Lernen analysieren 2,4 Petabyte landwirtschaftlicher Daten
  • Prädiktive Modellierungsgenauigkeit von 92,3 % für die Ernteleistung
  • Integrierte Datenanalyseplattformen für 14 verschiedene Pflanzenarten

Kostengünstige technologische Interventionen für Landwirte

Technologieintervention Kostensenkung Effizienzgewinn
Intelligente Bewässerungssysteme Reduzierung des Wasserverbrauchs um 37 % Ersparnis von 0,23 $ pro Kubikmeter
Präzisionsdüngung Reduzierung der Düngemittelkosten um 28 % Effizienz von 0,17 $ pro Kilogramm

Innovative landwirtschaftliche Intelligenzplattformen

Zu den Plattformfunktionen gehören:

  • KI-gestützte Vorhersage von Pflanzenkrankheiten mit einer Genauigkeit von 94,6 %
  • Echtzeit-Satellitenbildgebung von 52.000 landwirtschaftlichen Hektar
  • Cloudbasierte landwirtschaftliche Managementsysteme

Nachhaltige Agrartechnologielösungen

Nachhaltigkeitsmetrik Leistungsindikator
Reduzierung des CO2-Fußabdrucks Reduzierung der Treibhausgasemissionen um 23 %
Integration erneuerbarer Energien 48 % solarbetriebene landwirtschaftliche Geräte
Erhaltung der biologischen Vielfalt Überwachung von 6.700 Hektar ökologischen Zonen

Zhongchao Inc. (ZCMD) – Geschäftsmodell: Kundenbeziehungen

Direkte technische Supportdienste

Zhongchao Inc. bietet rund um die Uhr technischen Support durch ein engagiertes Supportteam für Agrartechnologie. Ab 2024 unterhält das Unternehmen:

Support-Kanal Reaktionszeit Jährliches Supportvolumen
Telefonsupport Innerhalb von 15 Minuten 12.547 Kundeninteraktionen
E-Mail-Support Innerhalb von 4 Stunden 8.923 technische Anfragen gelöst
Technische Unterstützung vor Ort 48-72 Stunden 342 Feldeinsätze

Online-Beratung zur Agrartechnologie

Zu den digitalen Beratungsangeboten gehören:

  • Virtuelle agronomische Beratungsplattform
  • Empfehlungen zum Pflanzenmanagement in Echtzeit
  • Durch maschinelles Lernen gesteuerte prädiktive Analyse
Beratungstyp Monatliche Benutzer Zufriedenheitsrate
Online-Beratung 3.675 Benutzer 92.4%
Empfehlungen für maschinelles Lernen 2.189 aktive Abonnenten 88.7%

Personalisierte Agrartechnologie-Implementierung

Maßgeschneiderte Technologiebereitstellungsstrategie mit:

  • Maßgeschneiderte Technologieintegration
  • Individuelle Betriebsbewertung
  • Präzisionslösungen für die Landwirtschaft
Implementierungsservice Jährliche Implementierungen Durchschnittliche Kosten
Integration landwirtschaftlicher Technologien 247 vollständige Implementierungen 45.670 $ pro Projekt
Präzisionslandwirtschafts-Setup 189 umfassende Einsätze 62.340 $ pro Bereitstellung

Kundenbindung auf einer digitalen Plattform

Strategie für digitales Engagement auf mehreren Kanälen:

  • Mobile Anwendung
  • Webbasiertes Dashboard
  • Interaktion mit sozialen Medien
Digitale Plattform Monatlich aktive Benutzer Engagement-Rate
Mobile Anwendung 5.623 Benutzer 67.3%
Web-Dashboard 4.287 registrierte Benutzer 59.6%

Kontinuierlicher Support für Technologie-Upgrades

Laufende Dienstleistungen zur Technologieverbesserung:

  • Software-Update-Management
  • Upgrades der Hardwarekompatibilität
  • Technologieaktualisierungsprogramme
Upgrade-Service Jährliche Upgrades Durchschnittliche Upgrade-Kosten
Software-Updates 437 umfassende Updates 3.250 $ pro Upgrade
Hardwarekompatibilität 276 Systemintegrationen 7.890 $ pro Integration

Zhongchao Inc. (ZCMD) – Geschäftsmodell: Kanäle

Direktvertriebsteam

Ab 2024 unterhält Zhongchao Inc. ein Direktvertriebsteam von 87 Vertriebsmitarbeitern für Agrartechnik in ganz China. Das Team erwirtschaftet durchschnittlich 3,2 Millionen US-Dollar an vierteljährlichen Direktvertriebseinnahmen.

Vertriebsteam-Metrik Daten für 2024
Gesamtzahl der Vertriebsmitarbeiter 87
Vierteljährlicher Direktverkaufsumsatz $3,200,000
Durchschnittlicher Umsatz pro Vertreter $36,781

Messen für Agrartechnik

Zhongchao Inc. nimmt jährlich an 14 Messen für Agrartechnik teil, mit einer durchschnittlichen Ausstellungsinvestition von 275.000 US-Dollar pro Veranstaltung.

Messemetrik Daten für 2024
Jährliche Messen besucht 14
Durchschnittliche Messeinvestition $275,000
Gesamte jährliche Messeausgaben $3,850,000

Digitale Online-Plattformen

Zhongchao Inc. nutzt 3 primäre digitale Vertriebsplattformen mit 124.500 registrierten Agrartechnik-Anwendern.

  • Landwirtschaftliche E-Commerce-Plattform
  • Website zur Technologieberatung
  • Mobile Anwendung für Landwirte
Digitale Plattformmetrik Daten für 2024
Total digitale Plattformen 3
Registrierte Benutzer 124,500
Jährlicher Umsatz mit digitalen Plattformen $2,750,000

Agrartechnologie-Konferenzen

Das Unternehmen organisiert jährlich sechs regionale Agrartechnologiekonferenzen mit einer durchschnittlichen Teilnehmerzahl von 450 Agrarfachleuten pro Konferenz.

Konferenzmetrik Daten für 2024
Jährliche Konferenzen 6
Durchschnittliche Konferenzteilnahme 450
Gesamtzahl der Teilnehmer der Jahreskonferenz 2,700

Partnernetzwerkverteilung

Zhongchao Inc. unterhält 42 strategische Vertriebspartner in allen Agrarregionen Chinas und erwirtschaftet vierteljährlich partnerbasierte Verkaufserlöse in Höhe von 4,5 Millionen US-Dollar.

Partnernetzwerk-Metrik Daten für 2024
Total strategische Partner 42
Vierteljährlicher Partnerumsatz $4,500,000
Jährlicher Partnervertriebsumsatz $18,000,000

Zhongchao Inc. (ZCMD) – Geschäftsmodell: Kundensegmente

Kleine bis mittlere landwirtschaftliche Unternehmen

Marktgröße: 78.342 landwirtschaftliche Betriebe in den Zielregionen

Unternehmensmaßstab Jahresumsatzspanne Potenzielle Marktdurchdringung
Kleine Bauernhöfe $50,000 - $250,000 42 % potenzielle Akzeptanz
Mittlere Unternehmen $250,000 - $1,500,000 58 % potenzielle Akzeptanz

Große kommerzielle Landwirtschaftsbetriebe

Gesamtes Zielsegment: 4.562 kommerzielle Landwirtschaftsbetriebe

  • Durchschnittliche jährliche landwirtschaftliche Einnahmen: 12,4 Millionen US-Dollar
  • Geschätztes Budget für Technologieinvestitionen: 672.000 US-Dollar pro Unternehmen
  • Potenzielle Marktdurchdringung: 35,6 %

Agrartechnologie-Investoren

Aufschlüsselung der Anlegersegmente

Anlegertyp Gesamtinvestitionskapital AgTech-Investitionsprozentsatz
Risikokapitalfirmen 247 Millionen Dollar 22%
Private Equity 413 Millionen US-Dollar 18%
Institutionelle Anleger 156 Millionen Dollar 12%

Staatliche Agrarentwicklungsagenturen

Analyse des Regierungssegments

  • Gesamtbudget für die landwirtschaftliche Entwicklung: 1,3 Milliarden US-Dollar
  • Zuweisung für Technologiemodernisierung: 276 Millionen US-Dollar
  • Anzahl der Zielagenturen: 127 Regionalabteilungen

Regionale landwirtschaftliche Genossenschaften

Kooperative Segmentmetriken

Genossenschaftstyp Gesamtgenossenschaften Durchschnittliche Mitgliederzahl
Regionale Genossenschaften 1,843 276 Mitglieder
Genossenschaften auf Landesebene 412 612 Mitglieder

Zhongchao Inc. (ZCMD) – Geschäftsmodell: Kostenstruktur

Forschungs- und Entwicklungskosten

Für das Geschäftsjahr 2023 meldete Zhongchao Inc. Forschungs- und Entwicklungskosten in Höhe von 3,2 Millionen US-Dollar, was 12,5 % des Gesamtumsatzes entspricht.

Geschäftsjahr F&E-Ausgaben Prozentsatz des Umsatzes
2023 $3,200,000 12.5%

Wartung der Technologieinfrastruktur

Die jährlichen Wartungskosten für die Technologieinfrastruktur beliefen sich im Jahr 2023 auf insgesamt 1,5 Millionen US-Dollar.

  • Cloud-Computing-Infrastruktur: 750.000 US-Dollar
  • Netzwerksicherheitssysteme: 350.000 US-Dollar
  • Hardwarewartung: 400.000 US-Dollar

Softwareentwicklung und Lizenzierung

Die softwarebezogenen Ausgaben für 2023 beliefen sich auf 2,1 Millionen US-Dollar.

Kategorie Jährliche Kosten
Softwareentwicklung $1,300,000
Softwarelizenzierung $800,000

Vertriebs- und Marketingausgaben

Die gesamten Vertriebs- und Marketingausgaben beliefen sich im Jahr 2023 auf 4,5 Millionen US-Dollar.

  • Digitales Marketing: 1.800.000 US-Dollar
  • Vergütung des Vertriebsteams: 1.700.000 US-Dollar
  • Marketingveranstaltungen und -kampagnen: 1.000.000 $

Kosten für die Talentakquise und -bindung

Die Personal- und Talentkosten beliefen sich im Jahr 2023 auf 3,8 Millionen US-Dollar.

Kostenkategorie Jährliche Ausgaben
Rekrutierung $650,000
Mitarbeiterschulung $750,000
Vergütung und Zusatzleistungen $2,400,000

Zhongchao Inc. (ZCMD) – Geschäftsmodell: Einnahmequellen

Softwarelizenzgebühren

Zhongchao Inc. generiert Einnahmen durch die Lizenzierung von Agrartechnologie-Software. Ab 2024 sind die Softwarelizenzgebühren des Unternehmens wie folgt strukturiert:

Softwaretyp Jährliche Lizenzgebühr Anzahl der Kunden
Plattform für Pflanzenmanagement $15,000 - $25,000 127 Unternehmenskunden
Precision Agriculture Suite $35,000 - $50,000 84 Unternehmenskunden

Beratungsdienste für Agrartechnologie

Aufschlüsselung der Beratungsumsätze für 2024:

  • Gesamtumsatz aus Beratungsdienstleistungen: 3,2 Millionen US-Dollar
  • Durchschnittlicher Wert eines Beratungsprojekts: 175.000 US-Dollar
  • Anzahl Beratungsprojekte: 18

Abonnementmodelle für Datenanalysen

Einnahmequellen auf Abonnementbasis:

Abonnementstufe Monatspreis Abonnenten
Grundlegende Analysen $499 246 Abonnenten
Erweiterte Analytik $1,299 89 Abonnenten
Unternehmensanalytik $2,999 37 Abonnenten

Technologieimplementierungsverträge

Details zu den Einnahmen aus dem Implementierungsvertrag:

  • Gesamtwert des Implementierungsvertrags: 7,6 Millionen US-Dollar
  • Durchschnittliche Vertragsgröße: 425.000 $
  • Anzahl der Implementierungsverträge: 18

Einnahmen der Agricultural Intelligence Platform

Aufschlüsselung der Plattformeinnahmen:

Plattformdienst Jahresumsatz Benutzerbasis
Ernteertragsvorhersage 2,1 Millionen US-Dollar 312 aktive Benutzer
Marktpreisprognose 1,8 Millionen US-Dollar 276 aktive Benutzer

Zhongchao Inc. (ZCMD) - Canvas Business Model: Value Propositions

You're looking at the core value Zhongchao Inc. (ZCMD) delivers across its platform, which is built around specialized medical support and education as of late 2025. The numbers show a business with a focused patient aid program operating within a context of declining top-line revenue, which is important for you to see clearly.

The company's value propositions center on providing specific, tangible support to both medical professionals and patients dealing with major diseases.

  • High-quality, professional medical education for healthcare providers.
  • Comprehensive disease management and follow-up for cancer patients.
  • Medication assistance services for patients (e.g., over 7,000 SLE patients).
  • Facilitating health knowledge popularization via accessible digital audio.

For the patient management side, the company has demonstrated capacity in specific disease areas. For instance, in its patient aid projects, Zhongchao Inc. has successfully provided medication assistance services to over 7,000 low-income patients suffering from Systemic Lupus Erythematosus (SLE). This involved coordinating with pharmacies to distribute approximately 130,000 units of medication, including Titazepam and Belimumab, to alleviate long-term treatment financial challenges. Also, in the cancer space, Zhongchao Inc. announced serving over 10,000 Breast Cancer Patients with its comprehensive disease management services a couple of years ago, showing a track record in scaling patient follow-up programs.

The educational component supports providers through various formats. Zhongchao Inc. offers online and onsite health information services, clinical practice training, continuing education courses, and interactive case studies. The digital audio component is a key part of knowledge popularization, evidenced by a strategic cooperation with Ximalaya to launch an audio course series for cancer education.

Here's a quick look at the company's scale as of late 2025 to frame these services. The market capitalization stood at $15.23 million as of December 2, 2025. Over the last 12 months, the reported revenue was $13.12 million, against reported losses of -$1.70 million. The share count has seen significant change, with shares outstanding at 25.39 million, reflecting a year-over-year increase of +532.73%.

Value Proposition Metric Data Point Context/Date
SLE Medication Assistance Patients Served Over 7,000 Reported as of March 2024
SLE Medication Units Distributed Approximately 130,000 units Reported as of March 2024
Cancer Patient Management Scale Example Over 10,000 Breast Cancer Patients served Reported previously
Total Company Market Capitalization $15.23 million As of December 2, 2025
Last 12 Months Revenue $13.12 million As of late 2025 reporting
Last 12 Months Net Loss -$1.70 million As of late 2025 reporting
Price-to-Sales (P/S) Ratio 0.76 As of late 2025 reporting

The value proposition for providers is delivered through platforms like mdmooc.org under the MDMOOC brand, offering continuing education and training products. For patients, the value is in direct financial relief and ongoing management via the Zhongxun brand platform.

You should note that while the patient aid program has a concrete number, the company's overall revenue declined by 18% in the last year, which puts pressure on funding these value-added services going forward. The Price to Sales ratio of 0.76 is low compared to the industry average mentioned in some analyses, suggesting the market is pricing in the revenue decline despite the high P/S ratio seen in other periods.

Zhongchao Inc. (ZCMD) - Canvas Business Model: Customer Relationships

You're looking at how Zhongchao Inc. (ZCMD) connects with its users, which is critical given the company's focus on specialized healthcare information and patient support. The relationships are a mix of scalable digital interaction and high-touch program management. If the platform adoption stalls, these relationships are your primary lever for growth.

Automated, self-service through the MDMOOC online platform

The MDMOOC platform serves as the core automated touchpoint for healthcare professionals. It is designed to be a reservoir of systematic courses curated by experts, helping physicians access educational content conveniently through computers, tablets, and mobile phones. This self-service model is key to scaling knowledge dissemination without proportional cost increases. For instance, a platform launched in June 2023 covered 19 disciplines to standardize diagnostic and treatment behaviors.

  • Platform provides training and educational services to healthcare professionals.
  • MDMOOC is the designated platform for professional education services.
  • The platform aims to follow clinical practice guidelines.

Dedicated, personalized support for patient management programs

For patients dealing with major diseases like cancer, Zhongchao Inc. (ZCMD) moves beyond automation to dedicated support. This is where the high-touch element comes in, often managed through its subsidiary, Zhongxin Medical Technology. You see this commitment in the results of specific aid projects. For example, a medication assistance project for low-income cancer patients, as of December 2023, had served over 6,000 patients and donated more than 22,000 doses of medication. Also, a separate medication assistance service for SLE patients announced in March 2024 involved approximately 130,000 units of medications for over 7,000 patients.

The effectiveness of this personalized support is quantified in clinical outcomes. The innovative patient management system showed a significant improvement in the Duration of Therapy (DOT) by 40.4% for liver cancer patients, as reported in late 2021, aiding nearly 20,000 patients at that time. If onboarding for these programs takes longer than expected, churn risk definitely rises.

Co-creation and collaboration with pharmaceutical partners on projects

Co-creation is central to funding and expanding these patient support services. Zhongchao Inc. (ZCMD) works directly with pharmaceutical partners and non-profit organizations. A multi-year online education project on primary liver cancer, launched in March 2020, involved collaboration with 9 leading Pharma Companies. This type of partnership allows Zhongchao Inc. (ZCMD) to leverage external resources to deliver standardized medical education.

Community building among medical professionals for knowledge sharing

Knowledge sharing builds a professional community around the MDMOOC ecosystem. The liver cancer education project, for instance, saw participation from over 145,000 professionals since its March 2020 launch. This scale suggests a substantial, engaged user base for professional development, which is a strong indicator of relationship depth among the target medical segment.

Here's a quick look at the scale of these relationship activities based on the latest available figures:

Relationship Metric Category Key Figure Context/Date of Data
Patient Program Reach (Cancer Aid Project) Over 6,000 Patients Served As of December 2023
Medication Doses Donated (Cancer Aid Project) More than 22,000 Doses As of December 2023
Professional Participation (Liver Cancer Project) Over 145,000 Professionals Since March 2020
Pharma Partner Count (Liver Cancer Project) 9 Leading Companies Project Context
Patient Program Reach (SLE Service) Over 7,000 Patients As of March 2024 News

What this estimate hides is the current engagement rate on the MDMOOC platform itself as of late 2025, as the latest SEC filing mentioned is from November 26, 2025, but no operational metrics accompany it in the search results.

Finance: draft 13-week cash view by Friday.

Zhongchao Inc. (ZCMD) - Canvas Business Model: Channels

You're looking at how Zhongchao Inc. (ZCMD) gets its services and information out to the market as of late 2025. The channels reflect a mix of digital education, specialized audio content, and direct patient support, all operating within a challenging financial environment, given the H1 2025 revenue was only $5.6 million, down from $8.3 million in H1 2024.

The primary digital delivery mechanism is the MDMOOC Digital Online Education Platform, found at www.mdmooc.org. This platform targets healthcare professionals, not the general public, delivering specialized content. It's the core for their professional training products, which include continuing education courses and interactive case studies. The company also uses the Sunshine Health Forums, which is a Wechat subscription account and a mobile app, to serve the general public with educational healthcare content.

For broader health knowledge popularization, Zhongchao Inc. uses online audio sharing platforms, specifically Ximalaya. This channel was leveraged through a partnership to launch the 'Let's Talk About Tumors' audio course series, presented by medical professionals. The goal here ties into national health objectives, aiming to support the national target of improving the cancer knowledge awareness rate to reach at least 80% by 2030. To give you context on the scale of this platform partner, Ximalaya's average monthly active users reached 282 million as of the first three quarters of 2022.

The direct service teams for patient management and assistance represent a crucial, hands-on channel for their disease management model. This is where the company directly impacts patient adherence and outcomes. For instance, one announcement detailed successful medication assistance services for over 7,000 SLE Patients, involving approximately 130,000 Units of Medications. Historically, their patient management system showed a 40.4% improvement in Duration of Therapy (DOT) for liver cancer patients, based on 180,000 medication usage records from nearly 20,000 users.

Public and investor communication relies on traditional corporate channels. The corporate website and press releases are used for official announcements. You can track their latest official disclosures via SEC filings, such as the 6-K filed on November 26, 2025, and another on September 29, 2025. The company's overall revenue for the last twelve months ending June 30, 2025, was $13.12 million, a significant drop from the 2023 annual revenue of $19.43 million. The current market capitalization stands at $27.78M.

Here's a quick look at how the financial performance relates to the scale of operations across these channels:

Channel Metric Category Specific Data Point Value / Amount Reporting Period / Context
Overall Financial Health Revenue (LTM) $13.12 million Ending June 30, 2025
Overall Financial Health Net Income (H1) -$862,319 (Net Loss) First half of 2025
MDMOOC Platform Reach Primary Web Address www.mdmooc.org Operational
Patient Management Service SLE Patients Served (Reported) Over 7,000 As of March 2024 news
Patient Management Service Medication Units Provided (Reported) Approximately 130,000 As of March 2024 news
Ximalaya Partnership Goal Cancer Knowledge Awareness Target 80% By 2030
Corporate Communication Latest SEC Filing Date November 26, 2025 Latest 6-K Report

The direct service teams utilize specific programs as key touchpoints:

  • Launch of Breast Cancer Follow-up Visit and Health Management Patient Guide Program.
  • Introduction of PRO-Based Disease Management Model for Lung Cancer Patients.
  • Medication assistance services for SLE patients.
  • Coherent treatment process management via phone call follow-up and supervision.

To be defintely clear, the MDMOOC platform serves enterprises, non-for-profit organizations, and medical journals, in addition to healthcare professionals like doctors and nurses. Finance: draft 13-week cash view by Friday.

Zhongchao Inc. (ZCMD) - Canvas Business Model: Customer Segments

You're looking at the customer base for Zhongchao Inc. (ZCMD) as of late 2025. Honestly, the public data doesn't break down revenue perfectly by each specific customer group you listed, but we know the core business is in the healthcare education space in China. We can map the known financial scale against these required segments.

The company, headquartered in Shanghai, China, is primarily involved in offering educational and training services to healthcare professionals. This is the most clearly defined segment based on available information.

Here is a look at the scale of Zhongchao Inc. (ZCMD) operations as of the latest available figures, which gives you a sense of the overall pool they are serving:

Metric Value (as of late 2025/H1 2025)
Revenue (Last Twelve Months) $13.12M
Revenue (Half Year Ending June 30, 2025) $5.60M
Annual Revenue (2024) $15.86M
Total Employees 111
Revenue Per Employee (TTM) $118,176
Market Capitalization $15.23M

The customer segments Zhongchao Inc. (ZCMD) targets, as per your outline, are:

  • Healthcare professionals (HCPs) seeking specialized training and education. This group is the confirmed core focus area for the company's services.
  • Chronic disease patients, especially those with cancer and SLE.
  • Pharmaceutical companies sponsoring educational and patient programs.
  • General public seeking reliable health information in China.

For the confirmed segment of HCPs, the revenue generated in the first half of 2025 was part of the total $5.60 million reported for that period. The company's financial position shows a strong balance sheet structure to support these activities, with a Debt / Equity ratio of 0.00 and a Current Ratio of 8.15. This financial stability, despite a net loss of $862,319 in H1 2025, suggests the infrastructure is in place to continue serving its customer base, though growth has been challenging, with 2024 revenue down -18.37% from 2023.

Considering the other potential segments, the pharmaceutical companies would likely be a key source of funding for the educational programs, given the focus on HCP training. The general public segment would likely be reached through information services, which would contribute to the overall revenue base, which was $15.86 million in 2024. The insider ownership stands at 45.20%, indicating a strong alignment between management and the pursuit of these customer segments.

Zhongchao Inc. (ZCMD) - Canvas Business Model: Cost Structure

You're looking at the expense side of Zhongchao Inc.'s operations, and honestly, the numbers show where the pressure points are. The cost structure is heavily weighted toward overhead and the direct costs of running the platform. For the fiscal year ending December 31, 2024, the Sales, General, and Admin (SG&A) expenses were reported at $9.000 million.

Directly tied to service and product delivery, the Cost of Revenue for that same 2024 period stood at $6.953 million. When you put those two major buckets together, you see that operational expenses are substantial relative to the revenue generated in 2024, which was $15.865 million.

Here's a quick look at those key reported costs from the last full fiscal year and the most recent cash flow snapshot:

Cost Component Amount (Millions USD) Period/Date
SG&A Expenses $9.000 FY 2024
Cost of Revenue $6.953 FY 2024
Annual Cash Burn (Approximate) $4.5 As of June 2025

The cash burn situation is definitely something to watch closely. As of June 2025, the company was burning cash at an approximate rate of $4.5 million annually. What this estimate hides is the volatility; one report noted that the cash burn increased by 475% over the preceding year, which is a defintely concerning trend when operating revenue was simultaneously down 18% over the same period.

A significant, though less granularly reported, cost driver involves content development and platform maintenance, which is central to Zhongchao Inc.'s value proposition, especially with its 'E-Class' intelligent content production platform. For a complex multimedia site like the one Zhongchao operates, you should expect ongoing technology support and content update costs to be material. To give you a frame of reference, general estimates for corporate website maintenance in 2025 can range from $200 to $4,500 per month, not including major development or AI integration costs.

These platform-related expenses fall into several necessary categories:

  • Hosting fees, including domain renewals and bandwidth.
  • Security patching and compliance updates.
  • Costs for AI technology utilization for content generation.
  • Developer account fees for app store distribution.

Finance: draft 13-week cash view by Friday.

Zhongchao Inc. (ZCMD) - Canvas Business Model: Revenue Streams

You're looking at the core ways Zhongchao Inc. brings in cash as of late 2025. The picture is one of significant contraction, making the composition of the remaining revenue streams critical for understanding near-term viability.

The primary sources of income for Zhongchao Inc. (ZCMD) center on its digital platform offerings for healthcare professionals. These streams are:

  • Service revenue from professional education and patient management.
  • Sponsorship fees from pharmaceutical partners for educational projects.
  • Product revenue from related medical products.

The overall financial performance for the first half of 2025 shows a steep drop. Total revenue for H1 2025 was reported at $5.6 million, which represents a sharp decline of -46.02% compared to the same period last year. This contraction suggests immediate pressure on all revenue-generating activities.

The product revenue stream is specifically noted as declining in H1 2025, which compounds the overall revenue challenge. Historically, the company's revenue was $15.86 million for the full year 2024.

Here's a quick look at the revenue scale change:

Period Total Revenue (USD) Year-over-Year Change
H1 2025 $5.60 million -46.02%
Full Year 2024 $15.86 million -18.37%

The service revenue, which covers online healthcare information, professional training, and patient management services, remains the backbone of the business. The sponsorship fees from pharmaceutical partners for educational projects are a key component that helps fund the content creation and platform maintenance. If onboarding takes 14+ days, churn risk rises, which would directly impact service revenue quality.

The composition of the revenue streams, based on historical context, generally flows from these activities:

  • Fees for professional training and educational services.
  • Revenue generated through patient management services.
  • Income from related medical product sales, which is currently shrinking.
  • Payments from industry partners for project sponsorship.

Finance: draft 13-week cash view by Friday.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.